Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


GREY:FRTX - Post by User

Post by skiptoggleon Nov 12, 2019 11:29am
193 Views
Post# 30340026

Conference Call Expectations

Conference Call ExpectationsSo the financials won't have much to report on due to the September cutoff.  So I don't think that the financials will be responsible for a bump up in price.
My question is will the company be willing AND able to report on production numbers to date?  Things that could be harbingers of good news for the Q4 and year end financials: flow rates, average uptime etc.  I am sure they would be willing (if they were positive) but would there be any legal/regulatory reasons to prevent them from doing so?
<< Previous
Bullboard Posts
Next >>